Back to today’s briefing

Story perspectives

Amid Gaffney's Hiatus, Major Health Discussions Emerge

4/19/2025

22 4

Summary

Story summary

Theresa Gaffney, lead writer at STAT, is taking a brief hiatus for travel. In her absence, critical discussions unfold around President Trump's AI strategy, the FDA's approval of Precision Neuroscience's groundbreaking brain-computer interface, and a rare disease naming debate led by Taylor Coffman. Meanwhile, NIH employees express growing frustration, and a new study reveals a concerning connection between hearing loss and dementia risk.

1 of 1

Story summary

Theresa Gaffney, lead writer at STAT, is taking a brief hiatus for travel. In her absence, critical discussions unfold around President Trump's AI strategy, the FDA's approval of Precision Neuroscience's groundbreaking brain-computer interface, and a rare disease naming debate led by Taylor Coffman. Meanwhile, NIH employees express growing frustration, and a new study reveals a concerning connection between hearing loss and dementia risk.